Jeffrey Joyce CV 11-8-12 - Kansas City University of Medicine and ...
Jeffrey Joyce CV 11-8-12 - Kansas City University of Medicine and ...
Jeffrey Joyce CV 11-8-12 - Kansas City University of Medicine and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Jeffrey</strong> N. <strong>Joyce</strong>, Ph.D. December 20<strong>12</strong>February 17, 1992, "Developmental dopamine plasticity, "Invited Speaker, Department <strong>of</strong>Pharmacology, Medical College <strong>of</strong> Pennsylvania, Philadelphia, PA.February 25, 1992, "Monoamine receptors, limbic pathology <strong>and</strong> schizophrenia,"Invited Speaker, Neuroscience Program Seminar Series, <strong>University</strong> <strong>of</strong>Illinois, Urbana-Champaign, ILMay 6, 1992, "Monoamines, limbic pathology <strong>and</strong> schizophrenia,", Invited Speaker, Symposia"Dopamine <strong>and</strong> Serotonin Interactions in Schizophrenia," American PsychiatricAssociation 14Sth Annual Meeting, Washington, D.C.May 24, 1992, "Developmental Plasticity <strong>of</strong> Dopamine Systems," Invited Speaker,7th International Catecholamine Symposium, Amsterdam, The Netherl<strong>and</strong>sJune 29, 1992, "Monoamine receptors, limbic pathology <strong>and</strong> schizophrenia,", InvitedSpeaker, Symposia "New Neuropathological Findings in Schizophrenia,"Collegium Internationale NeuroPsychopharmacologicum XVIIIth Annual Meeting,Nice.September 23, 1992, "The role <strong>of</strong> dopamine in receptor expression differs in the neonate <strong>and</strong> theadult," Invited Speaker, Department <strong>of</strong> Pharmacology, Temple <strong>University</strong>, Philadelphia,PA.October 5, 1992, "Damage to the early developing dopamine system permanently alters thematrix-directed dopamine system," Invited Speaker, International Basal GangliaSociety Meetings, Giens-Hymeres, FranceOctober 13, 1992, "Developmental plasticity <strong>of</strong> the dopamine system: role <strong>of</strong> dopamine as aneurotrophin," Invited Speaker, Junior Faculty Scholars Program, The Rockefeller<strong>University</strong>, New York, N.Y.November 16, 1992, "An anatomical basis for monoamine interactions in schizophrenia,"Invited Speaker, Department <strong>of</strong> Psychiatry, Mount Sinai School <strong>of</strong> <strong>Medicine</strong>, NewYork.December 18, 1992, "Characterization <strong>of</strong> the binding <strong>of</strong> [<strong>12</strong>5I]epidepride <strong>and</strong> [<strong>12</strong>5I]NCQ 298binding to D2 <strong>and</strong> D3-like dopamine receptors in human brain," Panel "PET Studies <strong>of</strong>Dopamine Function, American College <strong>of</strong> Neuropsychopharmcology Annual Meeting,San Juan, Puerto Rico.January 24, 1993, "Therapeutics <strong>of</strong> Parkinson's disease: new insights into oldquestions," Workshop, Twenty-Sixth Annual Winter Conference on BrainResearch, Whistler, BC, Canada.May 27, 1993, "Psychosis, Dementia <strong>and</strong> the Medial Temporal Lobe, " Symposium Chair,146th Annual Meeting, American Psychiatric Association, San Francisco,California ..December 16, 1993, "Anatomy <strong>of</strong> the 5-HTIA receptor <strong>and</strong> 5-HT transporter ([<strong>12</strong>5IRTI-55<strong>and</strong> [3H]paroxetine) in human brain: alterations in schizophrenia, Panel: 5-HT lAreceptor: molecular regualtion, endocrine control <strong>and</strong> schizophrenia, AmericanCollege <strong>of</strong> Neuropsychopharmacology, 32nd Annual Meeting, Honolulu, Hawaii.April 8, 1994, "Novel Dopamine Receptors: Alterations in Alzheimer's Disease," InvitedSpeaker, Sun Health Research Center, Sun <strong>City</strong>, AZ.April 13, 1994, "Novel Dopamine Systems in Human Brain: Implications for Underst<strong>and</strong>ingSchizophrenia," Invited Speaker, UpJohn Pharmaceuticals, Kalamazoo, MI.22
Change language